Lots of Drama, Few Answers at EpiPen Hearing

Lots of Drama, Few Answers at EpiPen Hearing-morningconsult: Mylan Pharmaceuticals CEO Heather Bresch revealed little new information about the price of EpiPens while testifying before a House committee Wednesday, leaving lawmakers dissatisfied.